CCM
ANAB icon

Coldstream Capital Management’s AnaptysBio ANAB Stock Holding History

Coldstream Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-345
Closed -$6.41K – 1224
2025
Q1 		$6.41K Buy
+345
New +$5.75K ﹤0.01% 2580

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Coldstream Capital Management's ANAB Position: Q2 2025 in Review

Coldstream Capital Management sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 345 shares — an estimated $6.41K sold.

Coldstream Capital Management first reported a position in ANAB in Q1 2025 and held it in 1 quarter. The position peaked at $6.41K in Q1 2025. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.

  • Coldstream Capital Management reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 345 AnaptysBio shares in Q2 2025, an estimated $6.41K.
  • Coldstream Capital Management first reported a position in AnaptysBio in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's AnaptysBio position peaked at $6.41K in Q1 2025.
  • 147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.